Host resistance to lipopolysaccharides in the pathogenesis of multiple sclerosis and membranoproliferative glomerulonephritis (Q39467740)

12 September 2017

title

Host resistance to lipopolysaccharides in the pathogenesis of multiple sclerosis and membranoproliferative glomerulonephritis (English)

1 reference

12 September 2017

0 references

1 reference

1 reference

1 reference

U Back

1 reference

12 September 2017

B B Moller

series ordinal

1 reference

12 September 2017

T C Bog-Hansen

series ordinal

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 July 1976

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

issue

7978

1 reference

12 September 2017

page(s)

188-192

1 reference

Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Bacterial and dietary antibodies in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

C2 deficiency. Development of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Host defense against bacterial endotoxemia: mechanism in normal animals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

[INVESTIGATIONS CONCERNING ENZYMES OF HUMAN BLOOD, VIII. THE POSSIBLE ROLE OF ARYLESTERASE I IN HUMAN FAT METABOLISM]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Endotoxins and the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Mechanism of B-Lymphocyte Activation: Failure to Obtain Evidence of a Direct Role of the Ig Receptors in the Triggering Process

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

A simplified bioassay for organophosphate detoxification and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

BRAIN ESTERASES AND PHOSPHATASES IN MULTIPLE SCLEROSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

On the association of non-specific esterase activity with central nerve myelin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Esterases in developing CNS myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Alterations in Plasma and Brain Lipid Metabolism during Endotoxemia in the Neonatal Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Letter: Multiple sclerosis with hypocomplementaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Partial purification and characterization of a lymphotoxic factor from multiple sclerosis serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Oligoclonal immunoglobulin G in multiple sclerosis brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

The C3 nephritic factor and membranoproliferative nephritis: correlation of serum levels of the nephritic factor with C3 levels, with therapy, and with progression of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Serum complement component studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Serum C'3 lytic system in patients with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

The Complement Abnormalities of Lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Editorial: An evaluation of risks--bypass versus obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

Control of spillover. The importance of Kupffer-cell function in clinical medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992358-8

7 January 2021

10.1016/S0140-6736(76)92358-8

Identifiers

DOI

1 reference

12 September 2017

1 reference